• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运动神经元存活蛋白(SMN)的Tudor结构域和C末端结构域中的突变会使该蛋白不稳定。

SMA mutations in SMN Tudor and C-terminal domains destabilize the protein.

作者信息

Takarada Toru, Ar Rochmah Mawaddah, Harahap Nur Imma Fatimah, Shinohara Masakazu, Saito Toshio, Saito Kayoko, Lai Poh San, Bouike Yoshihiro, Takeshima Yasuhiro, Awano Hiroyuki, Morioka Ichiro, Iijima Kazumoto, Nishio Hisahide, Takeuchi Atsuko

机构信息

Analytical Laboratory, Kobe Pharmaceutical University, Kobe, Japan.

Department of Community Medicine and Social Healthcare Science, Kobe University Graduate School of Medicine, Kobe, Japan.

出版信息

Brain Dev. 2017 Aug;39(7):606-612. doi: 10.1016/j.braindev.2017.03.002. Epub 2017 Mar 31.

DOI:10.1016/j.braindev.2017.03.002
PMID:28366534
Abstract

BACKGROUND AND PURPOSE

Most spinal muscular atrophy (SMA) patients are homozygous for survival of motor neuron 1 gene (SMN1) deletion. However, some SMA patients carry an intragenic SMN1 mutation. Such patients provide a clue to understanding the function of the SMN protein and the role of each domain of the protein. We previously identified mutations in the Tudor domain and C-terminal region of the SMN protein in three Japanese SMA patients. To clarify the effect of these mutations on protein stability, we conducted expression assays of SMN with mutated domains.

PATIENTS AND METHODS

Patients A and B carried a mutation in SMN1 exon 3, which encodes a Tudor domain, c.275G>C (p.Trp92Ser). Patient C carried a mutation in SMN1 exon 6, which encodes a YG-box; c.819_820insT (p.Thr274Tyrfs). We constructed plasmid expression vectors containing wild-type and mutant SMN1 cDNAs. After transfection of HeLa cells with the expression plasmids, RNA and protein were isolated and analyzed by reverse-transcription PCR and western blot analysis.

RESULTS

The abundance of wild-type and mutant SMN1 transcripts in HeLa cells was almost the same. However, western blot analysis showed lower levels of mutant SMN proteins compared with wild-type SMN. In mutant SMN proteins, it is noteworthy that the level of the p.Thr274Tyrfs mutant was much reduced compared with that of the p.Trp92Ser mutant.

CONCLUSIONS

SMN mutations may affect the stability and levels of the protein.

摘要

背景与目的

大多数脊髓性肌萎缩症(SMA)患者的运动神经元存活基因1(SMN1)缺失为纯合子。然而,一些SMA患者携带基因内SMN1突变。这类患者为理解SMN蛋白的功能及其各结构域的作用提供了线索。我们之前在三名日本SMA患者中鉴定出了SMN蛋白的Tudor结构域和C末端区域的突变。为阐明这些突变对蛋白质稳定性的影响,我们对具有突变结构域的SMN进行了表达分析。

患者与方法

患者A和B在编码Tudor结构域的SMN1外显子3中携带一个突变,c.275G>C(p.Trp92Ser)。患者C在编码YG盒的SMN1外显子6中携带一个突变,c.819_820insT(p.Thr274Tyrfs)。我们构建了包含野生型和突变型SMN1 cDNA的质粒表达载体。用表达质粒转染HeLa细胞后,分离RNA和蛋白质,并通过逆转录PCR和蛋白质印迹分析进行检测。

结果

HeLa细胞中野生型和突变型SMN1转录本的丰度几乎相同。然而,蛋白质印迹分析显示,与野生型SMN相比,突变型SMN蛋白水平较低。在突变型SMN蛋白中,值得注意的是,与p.Trp92Ser突变体相比,p.Thr274Tyrfs突变体的水平显著降低。

结论

SMN突变可能影响蛋白质的稳定性和水平。

相似文献

1
SMA mutations in SMN Tudor and C-terminal domains destabilize the protein.运动神经元存活蛋白(SMN)的Tudor结构域和C末端结构域中的突变会使该蛋白不稳定。
Brain Dev. 2017 Aug;39(7):606-612. doi: 10.1016/j.braindev.2017.03.002. Epub 2017 Mar 31.
2
Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.脊髓性肌萎缩症患者基因内SMN1突变的分子与功能分析
Hum Mutat. 2005 Jan;25(1):64-71. doi: 10.1002/humu.20111.
3
[Mutation analysis of SMN1 gene in patients with spinal muscular atrophy].[脊髓性肌萎缩症患者SMN1基因的突变分析]
Zhonghua Er Ke Za Zhi. 2011 Jun;49(6):411-5.
4
Phenotypes of SMA patients retaining SMN1 with intragenic mutation.保留具有基因内突变的SMN1的脊髓性肌萎缩症患者的表型。
Brain Dev. 2021 Aug;43(7):745-758. doi: 10.1016/j.braindev.2021.03.006. Epub 2021 Apr 20.
5
Two Japanese Patients With SMA Type 1 Suggest that Axonal-SMN May Not Modify the Disease Severity.两名患有1型脊髓性肌萎缩症的日本患者表明,轴突性生存运动神经元蛋白可能不会改变疾病严重程度。
Pediatr Neurol. 2015 Jun;52(6):638-41. doi: 10.1016/j.pediatrneurol.2015.02.023. Epub 2015 Feb 28.
6
Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy.突变型SMN蛋白的稳定性和寡聚化决定脊髓性肌萎缩症的临床严重程度。
Genes (Basel). 2022 Jan 24;13(2):205. doi: 10.3390/genes13020205.
7
Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients.在一些脊髓性肌萎缩症(SMA)患者中,SMN1基因内的突变可能比SMN2的拷贝数对临床严重程度的影响更大。
Brain Dev. 2014 Nov;36(10):914-20. doi: 10.1016/j.braindev.2013.11.009. Epub 2013 Dec 17.
8
[Study of SMN gene in Chinese children with spinal muscular atrophy].中国脊髓性肌萎缩症患儿的SMN基因研究
Zhongguo Dang Dai Er Ke Za Zhi. 2010 Jul;12(7):539-43.
9
A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencing.一种用于脊髓性肌萎缩症中SMN1和杂交SMN基因分析的新方法,该方法采用长片段PCR随后进行测序。
J Hum Genet. 2015 May;60(5):233-9. doi: 10.1038/jhg.2015.16. Epub 2015 Feb 26.
10
Spinal muscular atrophy pathogenic mutations impair the axonogenic properties of axonal-survival of motor neuron.脊髓性肌萎缩症致病突变会损害运动神经元轴突生存的轴突生成特性。
J Neurochem. 2012 May;121(3):465-74. doi: 10.1111/j.1471-4159.2012.07689.x. Epub 2012 Mar 14.

引用本文的文献

1
Spinal muscular atrophy caused by compound heterozygous SMN1 mutations: two cases and literature review.由复合杂合 SMN1 突变引起的脊髓性肌萎缩症:两例病例报告及文献复习。
Neurol Sci. 2024 Dec;45(12):5605-5615. doi: 10.1007/s10072-024-07651-0. Epub 2024 Jul 8.
2
Diving into progress: a review on current therapeutic advancements in spinal muscular atrophy.深入探讨进展:脊髓性肌萎缩症当前治疗进展综述
Front Neurol. 2024 May 24;15:1368658. doi: 10.3389/fneur.2024.1368658. eCollection 2024.
3
Emerging Gene Therapy Approaches in the Management of Spinal Muscular Atrophy (SMA): An Overview of Clinical Trials and Patent Landscape.
新兴基因治疗方法在脊髓性肌萎缩症(SMA)管理中的应用:临床试验和专利现状概述。
Int J Mol Sci. 2023 Sep 6;24(18):13743. doi: 10.3390/ijms241813743.
4
Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy.突变型SMN蛋白的稳定性和寡聚化决定脊髓性肌萎缩症的临床严重程度。
Genes (Basel). 2022 Jan 24;13(2):205. doi: 10.3390/genes13020205.
5
The Importance of Digging into the Genetics of Genes in the Therapeutic Scenario of Spinal Muscular Atrophy.挖掘基因遗传学在脊髓性肌萎缩治疗方案中的重要性。
Int J Mol Sci. 2021 Aug 21;22(16):9029. doi: 10.3390/ijms22169029.
6
Genomic Variability in the Survival Motor Neuron Genes ( and ): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development.生存运动神经元基因(和 )中的基因组变异性:对脊髓性肌萎缩症表型和治疗学发展的影响。
Int J Mol Sci. 2021 Jul 23;22(15):7896. doi: 10.3390/ijms22157896.
7
Temperature-sensitive spinal muscular atrophy-causing point mutations lead to SMN instability, locomotor defects and premature lethality in .温度敏感型脊髓性肌萎缩症致病点突变导致. 运动缺陷和过早致死。
Dis Model Mech. 2020 May 22;13(5):dmm043307. doi: 10.1242/dmm.043307.
8
Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates.参与脊髓性肌萎缩症通路的分子因素作为可能的疾病修饰候选因素。
Curr Genomics. 2018 Aug;19(5):339-355. doi: 10.2174/1389202919666180101154916.
9
How do SMA-linked mutations of SMN1 lead to structural/functional deficiency of the SMA protein?与脊髓性肌萎缩症相关的运动神经元存活基因1(SMN1)突变是如何导致脊髓性肌萎缩症蛋白出现结构/功能缺陷的?
PLoS One. 2017 Jun 1;12(6):e0178519. doi: 10.1371/journal.pone.0178519. eCollection 2017.